Towards Healthcare
Pathology Laboratories Market to Lead USD 834.44 Bn by 2034

Pathology Laboratories Market Expansion Fueled by AI in 2025

Projections indicate that, the global pathology laboratories market will increase from USD 380.95 billion in 2024 to USD 834.44 billion by 2034, experiencing a CAGR of 8.2% over the next 10 years. The market is growing due to the rising demand for early disease diagnosis and advanced diagnostic testing. North America leads the market due to technological advancements and the development of digital pathology.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The global pathology laboratories market size marked US$ 380.95 billion in 2024 and is forecast to experience consistent growth, reaching US$ 412.19 billion in 2025 and US$ 834.44 billion by 2034 at a CAGR of 8.2%.

North America is leading the pathology laboratories market share by 40% due to its advanced healthcare infrastructure, strong presence of leading diagnostic providers, high adoption of digital pathology technologies, significant healthcare expenditure, and rising demand for cancer and chronic disease testing. Favorable regulatory frameworks and ongoing innovation further reinforce its leadership position.

Key trends include the integration of AI and digital pathology platforms, rising adoption of cloud-based data management systems, growing role of telepathology for remote consultations, strategic mergers and acquisitions to expand diagnostic reach, and strong focus on personalized medicine through molecular and genomic testing

Global market growth is being boosted by the rising global disease burden, growing demand for early and accurate diagnostic services, increasing adoption of AI and digital technologies in pathology, expansion of specialized molecular testing, and consolidation trends among major diagnostic providers.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Food and Agriculture Organization (FAO) – healthcare diagnostics reports, US Food and Drug Administration (FDA), European Medicines Agency (EMA), Ministry of Health and Family Welfare, Government of India, National Cancer Institute (NCI), and World Bank – healthcare expenditure data
Any Questions